Kazachenka, Anastasiya
Young, George R.
Attig, Jan
Kordella, Chrysoula
Lamprianidou, Eleftheria
Zoulia, Emmanuela
Vrachiolias, George
Papoutselis, Menelaos
Bernard, Elsa
Papaemmanuil, Elli
Kotsianidis, Ioannis
Kassiotis, George http://orcid.org/0000-0002-8457-2633
Funding for this research was provided by:
Francis Crick Institute (FC001099)
Wellcome Trust (102898/B/13/Z)
Article History
Received: 7 August 2019
Accepted: 15 December 2019
First Online: 23 December 2019
Ethics approval and consent to participate
: The study described in this manuscript was approved by the institutional review board of the General University Hospital of Alexandroupolis, Greece. All participants provided written informed consent. The study also used publically available data; the human ethics board of each institution approved the original studies, and all patients provided written consent to the analysis of their data [CitationRef removed,CitationRef removed]. The studies were conducted in accordance with the ethical guidelines of the Declaration of Helsinki.
: Not applicable.
: GK is a scientific co-founder of and consulting for ERVAXX and a member of its scientific advisory board. GRY is consulting for ERVAXX. All remaining authors declare that they have no competing interests.